MacroGenics (MGNX) Earnings Date & Reports

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MGNX is expected to report earnings to fall 73.62% to -29 cents per share on November 04

Q3'26

Est.

$-0.29

Q2'26

Missed

by $1.02

Q1'26

Missed

by $0.01

Q4'25

Missed

by $0.03

Q3'25

Beat

by $0.68

The last earnings report on August 13 showed earnings per share of -110 cents, missing the estimate of -7 cents. With 173.69K shares outstanding, the current market capitalization sits at 255.44M.

View a ticker or compare two or three

MGNX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for MGNX